Metabolix To Present PLA Performance Improvements Using PHA Performance
Modifiers At 3rd Annual PLA World Congress
CAMBRIDGE, Mass., May 27, 2014
CAMBRIDGE, Mass., May 27, 2014 /PRNewswire/ --Metabolix, Inc. (NASDAQ: MBLX),
an advanced biomaterials company focused on sustainable solutions for the
plastics and chemicals industries, today announced that it will highlight
advances in its PHA (polyhydroxyalkanoate) biopolymer technology and its uses
in modifying PLA (polylactic acid) at the 3^rd PLA World Congress taking place
May 27 and 28 in Munich, Germany. Metabolix Vice President, Biopolymers, Bob
Engle will present on PHA performance modifiers for PLA at the conference.
"There is a significant opportunity to expand the range of applications
addressable by PLA, the current industry-leading biopolymer material, by
rubber toughening it with PHA modifiers," Engle said. "We are developing
proprietary PHA copolymer technology that is compatible with PLA and can
modify PLA's properties to provide significant improvement in toughness and
ductility, while still satisfying the market need for high bio-content and
compostable solutions in applications such as single-use nonwovens, blister
packaging and film."
Overview of Metabolix's PLA World Congress Presentation:
"PLA Modification Using New Mirel™ PHA Copolymers"
Tuesday, May 27 at 4:35 p.m. CEST
Metabolix has developed amorphous copolymers characterized with low glass
transition temperatures to extend its PHA biopolymer performance capabilities.
These PHA copolymers can effectively improve PLA's physical properties without
compromising transparency, bio-content or compostability. Metabolix will
showcase opportunities in a range of applications including fibers, sheet and
film that are enabled by using Metabolix PHA modifier technology and highlight
data on the PLA performance improvement. Metabolix is launching PLA
masterbatch compounds incorporating the new Mirel PHA copolymers.
Metabolix, Inc. is an advanced biomaterials company focused on sustainable
solutions for the plastics and chemicals industries. The Company is developing
and commercializing a family of high-performance biopolymers targeted at
applications for performance additives that can improve performance and/or
reduce cost in other material systems such as PVC, PLA and coated paper.
Metabolix also is developing platforms for biobased chemicals based on its
novel "FAST" recovery process and for co-producing plastics, chemicals and
energy from crops. Metabolix has established an industry-leading intellectual
property portfolio that, together with its knowledge of advanced industrial
practice, provides a foundation for industry collaborations.
For more information, please visitwww.metabolix.com.
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements which are made pursuant
to the safe harbor provisions of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended.
The forward-looking statements in this release do not constitute guarantees of
future performance. Investors are cautioned that statements in this press
release which are not strictly historical statements, including, without
limitation, statements regarding expectations for market demand and Metabolix
product development, constitute forward-looking statements. Such
forward-looking statements are subject to a number of risks and uncertainties
that could cause actual results to differ materially from those anticipated,
including the risks and uncertainties detailed in Metabolix's filings with the
Securities and Exchange Commission. Metabolix assumes no obligation to update
any forward-looking information contained in this press release or with
respect to the announcements described herein.
SOURCE Metabolix, Inc.
Contact: Metabolix Contact: Lynne H. Brum, 617-682-4693, LBrum@metabolix.com;
Media Inquiries: MSLGROUP, Keith Giannini or Danielle Kirsch at 781-684-0770
Press spacebar to pause and continue. Press esc to stop.